New York State Common Retirement Fund
ORMP icon

New York State Common Retirement Fund’s Oramed Pharmaceuticals ORMP Stock Holding History

New York State Common Retirement Fund’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26K Buy
+5,400
New +$21.5K ﹤0.01% 3102
2022
Q3 		– Sell
-260
Closed -$1K – 3402
2022
Q2 		$1K Sell
260
-21,404
-99% -$114K ﹤0.01% 3387
2022
Q1 		$187K Sell
21,664
-881
-4% -$9.03K ﹤0.01% 2843
2021
Q4 		$322K Buy
22,545
+4,576
+25% +$95.7K ﹤0.01% 2673
2021
Q3 		$395K Sell
17,969
-4,931
-22% -$84K ﹤0.01% 2597
2021
Q2 		$306K Buy
+22,900
New +$262K ﹤0.01% 2838

Other funds holding ORMP

Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

New York State Common Retirement Fund's ORMP Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Oramed Pharmaceuticals (ORMP) in Q2 2026: 5,400 shares worth $26K. The stake represents ﹤0.01% of the portfolio and ranks #3102 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in ORMP as recently as Q2 2022.

New York State Common Retirement Fund first reported a position in ORMP in Q2 2021 and has held it in 6 quarters since. The position peaked at $395K in Q3 2021. 84 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

  • New York State Common Retirement Fund held 5,400 shares of Oramed Pharmaceuticals worth $26K as of Q2 2026.
  • Oramed Pharmaceuticals was a new New York State Common Retirement Fund position in Q2 2026.
  • Oramed Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #3102 holding.
  • New York State Common Retirement Fund first reported a position in Oramed Pharmaceuticals in Q2 2021 and has held it in 6 quarters since.
  • New York State Common Retirement Fund's Oramed Pharmaceuticals position peaked at $395K in Q3 2021.
  • 84 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.